ARTICLE | Clinical News
Genfit preclinical data
October 10, 2011 7:00 AM UTC
In a mouse model of NAFLD/NASH, oral GFT505 prevented inflammation and the accumulation of fat, as well as reduced plasma concentrations of alanine aminotransferase (ALT). GFT505 also prevented intra-...